Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
1481 results found
2023 ∙ Gao, P. Kang, L. Y. Liu, J. Liu, M.
Immunogenicity, effectiveness, and safety of COVID-19 vaccines among children and adolescents aged 2-18 years: an updated systematic review and meta-analysis
Children Adolescents COVID-19 Administration Efficacy/effectiveness Safety
Rating:
Critically low
2023 ∙ Griffin, D. W. J. Pai Mangalore, R. Hoy, J. F. McMahon, J. H.
Immunogenicity, effectiveness, and safety of SARS-CoV-2 vaccination in people with HIV
Adults COVID-19 Efficacy/effectiveness Safety
Rating:
Critically low
2023 ∙ Suteja, R. C. Salim, A. Suryanov, I. P. D. Tirtayasa, P. M. W. Duarsa, G. W. K.
Immunologic response and seroconversion following third-dose COVID-19 vaccination in solid organ transplant recipients: A meta-analysis
Adults Older adults COVID-19 Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Emmanouilidou-Fotoulaki, E. Karava, V. Dotis, J. Kondou, A. Printza, N.
Immunologic Response to SARS-CoV-2 Vaccination in Pediatric Kidney Transplant Recipients: A Systematic Review and Meta-Analysis
Children Adolescents Adults COVID-19 Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Chaubey, I. Vijay, H. Govindaraj, S. Babu, H. Cheedarla, N. Shankar, E. M. Vignesh, R. Velu, V.
Impact of COVID-19 Vaccination on Pregnant Women
Pregnant women COVID-19 Efficacy/effectiveness Safety
Rating:
Critically low
2023 ∙ Adu, P. Poopola, T. Medvedev, O. N. Collings, S. Mbinta, J. Aspin, C. Simpson, C. R.
Implications for COVID-19 vaccine uptake: A systematic review
Adults Older adults COVID-19 Acceptance
Rating:
Not applicable
2023 ∙ Soltanzadi, A. Mirmosayyeb, O. Momeni Moghaddam, A. Ghoshouni, H. Ghajarzadeh, M.
Incidence of Bell's palsy after Coronavirus disease (COVID-19) vaccination: a systematic review and meta-analysis
All age groups COVID-19 Safety
Rating:
Critically low
2023 ∙ Guo, B. Q. Li, H. B. Yang, L. Q.
Incidence of myopericarditis after mRNA COVID-19 vaccination: A meta-analysis with focus on adolescents aged 12–17 years
Adolescents COVID-19 Safety
Rating:
Moderate
2023 ∙ Santoli, G. Nurchis, M. C. Calabrò, G. E. Damiani, G.
Incremental Net Benefit and Incremental Cost-Effectiveness Ratio of COVID-19 Vaccination Campaigns: Systematic Review of Cost-Effectiveness Evidence
All age groups COVID-19 Economic aspects
Rating:
Not applicable
2023 ∙ Yenew, C. Dessie, A. M. Gebeyehu, A. A. Genet, A.
Intention to receive COVID-19 vaccine and its health belief model (HBM)-based predictors: A systematic review and meta-analysis
All age groups COVID-19 Acceptance
Rating:
Not applicable
Loading...